Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Pritham Reddy

Vascular Surgery Southfield, MI Medical Doctor

NPI 1134332919 CMS profile 96322

22250 Providence Dr, Suite 555, Southfield, MI 48075

Open in the dashboard

General payments

$3,497

74 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Pritham Reddy of Southfield, MI is reported in the CMS Open Payments database as having received $3,497 across 74 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 41st percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $531 9
2024 General $863 11
2023 General $559 9
2022 General $446 9
2021 General $510 14
2020 General $177 7
2019 General $412 15

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Pritham Reddy
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Pritham Reddy were reported at $531. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Pritham Reddy Vascular Surgery median Middle half National median
2019 $412 $796 $226–$2,363 $163
2020 $177 $348 $118–$1,110 $114
2021 $510 $471 $158–$1,421 $132
2022 $446 $725 $222–$2,183 $149
2023 $559 $836 $257–$2,440 $160
2024 $863 $909 $252–$2,619 $164
2025 $531 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Endologix, Inc. $1,756 11 payments
  2. Silk Road Medical, Inc. $297 7 payments
  3. Abbott Laboratories $143 3 payments
  4. AngioDynamics, Inc. $128 3 payments
  5. Smith+Nephew, Inc. $113 2 payments
  6. Bard Peripheral Vascular, Inc. $100 4 payments
  7. Bolton Medical Inc $78 3 payments
  8. Janssen Pharmaceuticals, Inc $77 5 payments
  9. Imperative Care, INc $75 2 payments
  10. W. L. Gore & Associates, Inc. $71 3 payments
  11. Other $661 31 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,497 74 payments
Products named General payments · program years 2019–2025
  1. Alto Abdominal Stent Graft System $856 6 payments
  2. ENDOCROSS Device $581 3 payments
  3. Torus Stent Graft System $581 3 payments
  4. AFX2 Bifurcated Endograft System $319 2 payments
  5. ENROUTE Transcarotid Neuroprotection System $297 7 payments
  6. ENROUTE Transcarotid Stent $297 7 payments
  7. SUPERA $122 2 payments
  8. PICO 7 Single Use Negative Pressure Wound Therapy $99 1 payment
  9. XARELTO $77 5 payments
  10. PRODIGY CATHETER $75 2 payments
  11. Other $1,253 57 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

109

Median for Vascular Surgery: 122

Drug cost

$26,377

Median for Vascular Surgery: $14,135

Branded share of claims

60.6%

Median for Vascular Surgery: 71%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 17 $18,242
Xarelto Rivaroxaban Brand 11 $6,731
Cilostazol Generic 25 $779
Clopidogrel Clopidogrel Bisulfate Brand 38 $574
Atorvastatin Calcium Generic 18 $51

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,087 Part D prescribers listed as Vascular Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 73 billing codes

Paid by Medicare

$142,619

Medicare's payments for the services billed

Medicare patients

405

Average age 74

Services billed

1,328

214 women, 191 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 56%
Diabetes 50%
Ischemic heart disease 48%
Chronic kidney disease 44%
Heart failure 34%
Atrial fibrillation 25%
COPD 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

74 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record